SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-050506
Filing Date
2019-09-23
Accepted
2019-09-23 19:38:23
Documents
1
Period of Report
2019-09-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3947
  Complete submission text file 0001209191-19-050506.txt   5686
Mailing Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458
Business Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 351 NEWTON MA 02458 (844) 902-6100
Acer Therapeutics Inc. (Issuer) CIK: 0001069308 (see all company filings)

IRS No.: 320426967 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O KALOBIOS PHARMACEUTICALS, INC. 260 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address
Joseph Donald (Reporting) CIK: 0001319460 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33004 | Film No.: 191109007